SCHEMBL15416672

SCHEMBL15416672

O=C(Cn1cnc2ccccc21)N1CCCC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.67
CYP2C9 P11712 2/20 0.60
CYP2C19 P33261 2/20 0.60
GAA P10253 1/20 0.60
PTGS2 P35354 1/20 0.60
KDM4E B2RXH2 1/20 0.57
NPC1 O15118 1/20 0.57
GRIN2B Q13224 2/20 0.55
TDP1 Q9NUW8 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HTT P42858 1/20 0.54
ALDH1A1 P00352 2/20 0.53
CXCR3 P49682 1/20 0.53
EGLN3 Q9H6Z9 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALPL P05186 2/20 0.51
ALPG P10696 2/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15473947 0.88 LMNA (0.61) LMNACYP2C9CYP2C19GAAPTGS2
SCHEMBL20458926 0.88 LMNA (0.58) LMNACYP2C9CYP2C19GAAPTGS2
SCHEMBL13779968 0.87 LMNA (0.67) LMNAPTGS2KDM4ENPC1TDP1
SCHEMBL8601897 0.87 NPSR1 (0.71) LMNACYP2C19PTGS2KDM4ENPC1
SCHEMBL15471365 0.85 LMNA (0.58) LMNACYP2C9CYP2C19GAAPTGS2
SCHEMBL2876672 0.81 KDM4E (0.60) LMNAGAAKDM4ESMN1; SMN2HTT
SCHEMBL13039592 0.79 LMNA (0.60) LMNAGAAPTGS2KDM4ENPC1
SCHEMBL1035783 0.78 EGLN3 (0.71) LMNACYP2C9CYP2C19PTGS2KDM4E
SCHEMBL26935481 0.78 HPGD (0.51) LMNAPTGS2NPC1GRIN2BNPSR1
SCHEMBL15337854 0.78 LMNA (0.53) LMNACYP2C9CYP2C19GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872502-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2015-05-20 EP disclosed
WO-2014009302-A1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2014-01-16 WO disclosed